Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00393-020-00878-0 http://scihub22266oqcxt.onion/10.1007/s00393-020-00878-0 32845393!7448266!32845393     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32845393&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Z+Rheumatol 2020 ; 79 (7): 686-691 Nephropedia Template TP {{tp|p=32845393|t=2020. SARS-CoV-2 & Rheuma : Konsequenzen der SARS-CoV-2-Pandemie fur Patienten mit entzundlich rheumatischen Erkrankungen Ein Vergleich der Handlungsempfehlungen rheumatologischer Fachgesellschaften und Risikobewertung verschiedener antirheumatischer Therapien |pdf=|usr=}}{{32845393}} gab.com Text SARS-CoV-2 & Rheuma : Konsequenzen der SARS-CoV-2-Pandemie fur Patienten mit entzundlich rheumatischen Erkrankungen Ein Vergleich der Handlungsempfehlungen rheumatologischer Fachgesellschaften und Risikobewertung verschiedener antirheumatischer Therapien JO: Z Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=32845393 #FOAvip The recommendations of the German Society of Rheumatology (DGRh) update, which update and expand the guidance on the management of patients with inflammatory rheumatic diseases in view of SARS-CoV?2 created at the beginning of the COVID-19 pandemic, correspond in many points with the recommendations for action of the American (ACR) and European (EULAR) societies, but also differ in some points. Therefore, this article discusses the core recommendations of the DGRh update on the prevention of SARS-CoV-2/COVID-19, the risk assessment for inflammatory rheumatic diseases and the use of antirheumatic treatments in the context and in comparison to the ACR and EULAR recommendations, and provides an overview of the risk assessment of individual antirheumatic drugs. Twit Text FOAVip SARS-CoV-2 & Rheuma : Konsequenzen der SARS-CoV-2-Pandemie fur Patienten mit entzundlich rheumatischen Erkrankungen Ein Vergleich der Handlungsempfehlungen rheumatologischer Fachgesellschaften und Risikobewertung verschiedener antirheumatischer Therapien ????Z Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=32845393 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32845393 #FOAvip English Wikipedia <ref>{{Cite pmid|32845393}}</ref> SARS-CoV-2 & Rheuma : Konsequenzen der SARS-CoV-2-Pandemie fur Patienten mit entzundlich rheumatischen Erkrankungen Ein Vergleich der Handlungsempfehlungen rheumatologischer Fachgesellschaften und Risikobewertung verschiedener antirheumatischer Therapien #MMPMID32845393 Leipe J; Hoyer BF; Iking-Konert C; Schulze-Koops H; Specker C; Kruger K Z Rheumatol 2020[Sep]; 79 (7): 686-691 PMID32845393show ga The recommendations of the German Society of Rheumatology (DGRh) update, which update and expand the guidance on the management of patients with inflammatory rheumatic diseases in view of SARS-CoV?2 created at the beginning of the COVID-19 pandemic, correspond in many points with the recommendations for action of the American (ACR) and European (EULAR) societies, but also differ in some points. Therefore, this article discusses the core recommendations of the DGRh update on the prevention of SARS-CoV-2/COVID-19, the risk assessment for inflammatory rheumatic diseases and the use of antirheumatic treatments in the context and in comparison to the ACR and EULAR recommendations, and provides an overview of the risk assessment of individual antirheumatic drugs. |*Rheumatology[MESH] |Antirheumatic Agents/*therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Coronavirus Infections/*epidemiology[MESH] |Europe[MESH] |Germany[MESH] |Humans[MESH] |Inflammation/*therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/*epidemiology[MESH] |Practice Guidelines as Topic[MESH] |Rheumatic Diseases/*therapy[MESH] |Risk Assessment[MESH] |SARS-CoV-2[MESH] |Societies, Medical[MESH]SARS-CoV-2 & Rheuma : Konsequenzen der SARS-CoV-2-Pandemie fur Patient(epmc).pdf DeepDyve Pubget Overpricing